Literature DB >> 9173990

Tardive dyskinetic syndrome in rats infected with Borna disease virus.

M V Solbrig1, G F Koob, J H Fallon, W I Lipkin.   

Abstract

Tardive Dyskinesia (TD) is a hyperkinetic movement disorder caused by chronic treatment of psychiatric patients with dopamine (DA) receptor blocking drugs (Stacy & Jankovic 1991). Although TD is one of the most important and frequently encountered iatrogenic disorders in clinical medicine, its pathophysiology is poorly understood. We have observed a hyperkinetic movement disorder in rats experimentally infected with a neurotropic RNA virus, Borna disease virus, that may provide important insights into the pathophysiology of TD. Like TD patients, infected rats show prominent orofacial dyskinesias. In keeping with the dopamine (Goetz & Klawans 1982) and anatomic (Fibiger & Lloyd 1984) hypotheses of TD, the Borna disease rat model shows enhanced behavioural sensitivity to DA agonists and selective striatal cell damage. There is also evidence of DA deafferentation and heterogeneous reduction of D2 binding in the caudate-putamen, particularly from sites implicated in oral behaviour. These observations on a virus-induced movement disorder offer novel approaches to TD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 9173990     DOI: 10.1006/nbdi.1994.0014

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  12 in total

Review 1.  Borna disease virus and human disease.

Authors:  K M Carbone
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

2.  Animal models of CNS viral disease: examples from borna disease virus models.

Authors:  Marylou V Solbrig
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-24

Review 3.  Borna disease virus.

Authors:  Mady Hornig; Thomas Briese; W Ian Lipkin
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

4.  A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats.

Authors:  Marylou V Solbrig; Yijun Fan; Neal Hermanowicz; Maria Grazia Morgese; Andrea Giuffrida
Journal:  Exp Neurol       Date:  2010-09-09       Impact factor: 5.330

5.  Activators of potassium M currents have anticonvulsant actions in two rat models of encephalitis.

Authors:  Marylou V Solbrig; Russell Adrian; Steven L Wechsler; George F Koob
Journal:  Eur J Pharmacol       Date:  2006-10-20       Impact factor: 4.432

6.  An infection-based model of neurodevelopmental damage.

Authors:  M Hornig; H Weissenböck; N Horscroft; W I Lipkin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

7.  Cannabinoid rescue of striatal progenitor cells in chronic Borna disease viral encephalitis in rats.

Authors:  Marylou V Solbrig; Neal Hermanowicz
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

8.  Animal models of virus-induced neurobehavioral sequelae: recent advances, methodological issues, and future prospects.

Authors:  Marco Bortolato; Sean C Godar
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-05-18

9.  Detection and sequence analysis of borna disease virus p24 RNA from peripheral blood mononuclear cells of patients with mood disorders or schizophrenia and of blood donors.

Authors:  Y Iwata; K Takahashi; X Peng; K Fukuda; K Ohno; T Ogawa; K Gonda; N Mori; S Niwa; S Shigeta
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Neuroprotection and reduced proliferation of microglia in ribavirin-treated bornavirus-infected rats.

Authors:  Marylou V Solbrig; Robert Schlaberg; Thomas Briese; Nigel Horscroft; W Ian Lipkin
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.